Jörg Hornstein
Vermögen: 469 034 $ am 30.06.2026
Vermögen: 469 034 $ am 30.06.2026
Jörg Hornstein is currently Chief Financial Officer & EVP-Corporate Functions at H.
Lundbeck A since 2022.
Former jobs include Divisional Chief Financial Officer at EMD Millipore Corp.
from 2010 to 2011, Chief Financial Officer-Indonesia Operations at Merck KGaA from 2002 to 2013, Chief Financial Officer & Executive Vice President at AC Immune SA, and Senior Vice President-Group Controlling at Unternehmensgruppe Theo Müller SCS from 2014 to 2017.
Education includes an MBA from London Business School and an undergraduate degree from Hankamer School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2025 | 72’188 ( 0.01% ) | 469 034 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| H. LUNDBECK A/S | Finanzdirektor/CFO | 01.09.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
Unternehmensgruppe Theo Müller SECS
Unternehmensgruppe Theo Müller SECS Agricultural Commodities/MillingProcess Industries Manufactures and distributes dairy products | Corporate Officer/Principal | 01.03.2017 |
| MERCK KGAA | Corporate Officer/Principal | 01.01.2013 |
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and production of biotechnology & pharmaceutical drug therapies | Corporate Officer/Principal | 01.12.2011 |
| AC IMMUNE SA | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and production of biotechnology & pharmaceutical drug therapies | Commercial Services |
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
H. Lundbeck A/S
H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
AC Immune SA
AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
London Business School
London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hankamer School of Business
Hankamer School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unternehmensgruppe Theo Müller SECS
Unternehmensgruppe Theo Müller SECS Agricultural Commodities/MillingProcess Industries Manufactures and distributes dairy products | Process Industries |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen